Legorreta Cancer Center

The Legorreta Cancer Center is building world-class cancer research programs that bring basic science discoveries about cancer, interdisciplinary clinical, translational, and population research to innovative therapeutic, disease intervention, and cancer prevention clinical trials to patients in the State of Rhode Island.

El-Deiry Cancer Research Laboratory

The El-Deiry Lab is a translational drug discovery and development lab focused on unraveling cell death signaling downstream of tumor suppressors p53 and TRAIL and developing novel therapeutic approaches for colorectal cancer. The lab does screening to discover new drugs, molecular and cellular analysis of new drug mechanisms, live tumor growth and drug effectiveness studies, and clinical trial development for testing of new treatments for patients with colorectal cancer.

Lifespan Cancer Institute

The Lifespan Cancer Institute at Rhode Island, The Miriam, and Newport hospitals is an active clinical trials site, committed to providing patients with the latest protocols. Our patients have access to groundbreaking new immunotherapies and other new and emerging cancer treatments at various stages of diagnosis and across many cancer types. Our medical professionals can answer questions and help determine whether participation in one of our research programs is beneficial for the patient.

New Patient Hotline: 1-844-222-2881

Brown University Oncology Research Group

The Brown University Oncology Research Group (BrUOG) is the principle mechanism for oncology clinical trials at the Alpert Medical School. This regional consortium of Brown-affiliated hospitals allows hematologists, oncologists, surgeons, radiation oncologists, pathologists, and others to develop investigator-initiated clinical trials. These studies are conceived and designed by faculty at member institutions.

Translational Research Disease Groups (TDRGs)

TRDGs comprise a multidisciplinary team of researchers and clinicians, oncologists, appropriate clinical faculty from various disciplines such as Hematology/Oncology, Radiation Oncology, Surgical Oncology, Pathology, as well as research-based faculty including cancer biology and genetics, population scientists, biostatistics and bioinformatics researchers, as well as fellows and student trainees. TRDG meetings provide opportunities for discussion of translational directions that may be eligible for pilot funds or for submission to suitable extramural funding opportunities.

Affiliated Hospitals